Kalbe Farma Tbk PT operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kalbe Farma Tbk PT with three other
pharmaceutical manufacturers in Asia:
Zhejiang Hisun Pharmaceutical, Ltd.
sales of 9.73 billion Chinese Renmimbi [US$1.41 billion]
of which 64%
was Drug/Medicine Sales),
Ono Pharmaceutical Co Ltd
(160.28 billion Japanese Yen [US$1.45 billion]
of which 31%
was Metabolic Medicine And Vitamin compound), and
Joincare Pharmaceutical Group Industry Company Limited
based in China
(9.72 billion Chinese Renmimbi [US$1.41 billion]
of which 99%
was Industry and Commerce).
Kalbe Farma Tbk PT reported sales of 19.37 trillion Indonesian Rupiahs (US$1.46 billion)
December of 2016.
increase of 8.3%
versus 2015, when the company's sales were 17.89 trillion Indonesian Rupiahs.
Sales at Kalbe Farma Tbk PT have increased during each of the previous five years
(and since 2011, sales have increased a total of 78%).
Sales of Consumer Health saw an increase
11.1% in 2016, from
3.07 trillion Indonesian Rupiahs to 3.41 trillion Indonesian Rupiahs.